Global Migraine Drugs Market Report 2021: Market to Reach $6.9 Trillion by 2027 - Key Players are Allergan Amgen, Inc. Biohaven Pharma, Ltd. Eli Lilly and Co, GSK, J&J, Pfizer, Teva Pharma - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Migraine Drugs - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Global Migraine Drugs Market to Reach $6.9 Trillion by 2027
Amid the COVID-19 crisis, the global market for Migraine Drugs estimated at US$2.3 Trillion in the year 2020, is projected to reach a revised size of US$6.9 Trillion by 2027, growing at a CAGR of 16.9% over the period 2020-2027.
Acute Treatment, one of the segments analyzed in the report, is projected to record 17.5% CAGR and reach US$5.4 Trillion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Preventive Treatment segment is readjusted to a revised 15.1% CAGR for the next 7-year period.
The U.S. Market is Estimated at $620.3 Billion, While China is Forecast to Grow at 22% CAGR
The Migraine Drugs market in the U.S. is estimated at US$620.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Trillion by the year 2027 trailing a CAGR of 21.9% over the analysis period 2020 to 2027.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.1% and 15% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 13.4% CAGR.
Key Topics Covered:
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of COVID-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS (Total 59 Featured):
- Allergan PLC
- Amgen, Inc.
- Biohaven Pharmaceutical Holding Company Ltd.
- Eli Lilly and Company
- GlaxoSmithKline PLC
- Johnson & Johnson
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
- United States
- United Kingdom
- Rest of Europe
- South Korea
- Rest Of Asia-Pacific
- Latin America
- Rest of Latin America
- Middle East
- Saudi Arabia
- United Arab Emirates
- Rest of Middle East
- Total Companies Profiled: 59
For more information about this report visit https://www.researchandmarkets.com/r/as9gwo
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900